Hair loss at Ozempic & Co.: How high the risk really is according to studies
According to researchers, the absolute risk of a medically documented form of hair loss is about three to nine cases per 1,000 people and..
Reliability 59 · moderateLIVE7 min ago
- Center-left1
- Center-right1
2 sources1 independent voice
1 agency rewrite / co-publication detected
Left & right
Summary
The rate was 4.24 percent for tirzepatid and 3.33 percent for semaglutide. For women, the values were 5.44 percent and 3.63 percent, respectively.
Cross-referenced from 2 sources.
Factual coreconfirmed by several independent voices
Insufficient core: not enough independent confirmations to retain a shared fact.
Reported detailssecondary facts, each attributed to its source
The rate was 4.24 percent for tirzepatid and 3.33 percent for semaglutide.
according to Frankfurter Rundschau +1For women, the values were 5.44 percent and 3.63 percent, respectively.
according to Frankfurter Rundschau +1
Disputedincompatible versions — to verify
No factual contradiction detected between sources.
Framing by sidesame fact, different words — loaded terms highlighted
No notable framing divergence.
Blind spotwhat one side keeps silent
No blind spot detected: every side covers the same facts.
Sources2 sources cross-checked
Center-left1
Center-right1
